Results may help scientists understand which older adults may have impaired immune systems, allowing early intervention to improve protection against infectious diseases, which remain a prominent killer in those over age 65.Continue reading
Philipp von Bieberstein’s research focuses on the plant Withania somnifera, a member of the tomato family that contains a potential anti-tumor agent.
A new study reconstructing the evolutionary tree of flu viruses challenges conventional wisdom and solves some of the mysteries surrounding flu outbreaks of historical significance
An innovative vaccine technology makes use of reengineered salmonella to deliver protective immunity. If such recombinant attenuated salmonella vaccines, or RASVs, can be perfected, they hold the promise of safe, low-cost, orally-administered defenses against viral, bacterial, fungal and parasitic infections.Continue reading
Study targets EGFR and FGFR cellular pathways to treat rare diseaseContinue reading
TUCSON, AZ, Feb 11, 2014 (Media Release) — HTG Molecular Diagnostics (“HTG”) today announced the initial closing of its Series E offering with existing investors Novo Ventures, SROne, Merck Capital Ventures, and Fletcher Spaght. Proceeds will support commercial and product development initiatives.Continue reading
New treatments might be possible for patients who now have little hopeContinue reading
NuvOx Pharma, a Tucson-based biotech startup, founded in 2008 is metamorphosing from an R&D startup to one that is testing the Company’s nanotechnology therapeutic platform in the clinic.Continue reading